22 results
8-K
EX-99.2
CTKB
Cytek BioSciences Inc
1 Mar 24
Cytek Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Outlook
6:06am
and reduces reagent waste. Notably, the Cytek Orion system is unique in that it is focused solely on cocktail making for sample preparation, enabling
8-K
EX-99.1
CTKB
Cytek BioSciences Inc
9 Nov 23
Q3 2023 Earnings Call
6:06am
, helping assure consistent experimental results, saving time and reducing reagent waste. We showcased our technology at recent industry conferences
10-K
tkyc9u3jd
17 Mar 22
Annual report
4:38pm
10-Q
jqzqe96x201879n5qw
3 Sep 21
Quarterly report
12:00am
424B4
1zxmlq5s157t
23 Jul 21
Prospectus supplement with pricing info
4:12pm
S-1/A
zmf8slkao2jahvbqmn8
13 Jul 21
IPO registration (amended)
9:03pm
S-1
vng2ptfvuhyl b597
2 Jul 21
IPO registration
4:34pm
S-1
EX-10.14
358q5bfr73 xa3
2 Jul 21
IPO registration
4:34pm
S-1
EX-10.13
ihnwyhxnvf89s766erb
2 Jul 21
IPO registration
4:34pm
DRS/A
EX-10.13
f6fma91hek1gshe
14 Jun 21
Draft registration statement (amended)
12:00am
DRS/A
EX-10.14
vbzbx01pfa
14 Jun 21
Draft registration statement (amended)
12:00am